Viewing Study NCT00538304


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-02-20 @ 6:41 PM
Study NCT ID: NCT00538304
Status: COMPLETED
Last Update Posted: 2019-04-23
First Post: 2007-09-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Sponsor: Allergan
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2019-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: